Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo

By M. Chen, M. Pittet, L. Gorelik, R. Flavell, Ralph Weissleder, H. von Boehmer, K. Khazaie. 2005

775 citations recorded by the source corpus.

Cancer patients can harbor significant numbers of CD8 and CD4 T cells with specificities to tumor antigens (Ags). Yet, in most cases, such T cells fail to eradicate the tumor in vivo. Here, we investigated the interference of Ag-specific CD4+CD25+ regulatory T cells (Treg) with the tumor-specific CD8 T cell immune response in vivo, by monitoring the homing, expansion, and effector function of both subsets in draining and nondraining lymph nodes. The results show that CD8 cells expand to the same extent and produce similar levels of IFN-γ in the presence or absence of Ag-specific Treg. Nevertheless, these Treg abrogate CD8 T cell-mediated tumor rejection by specifically suppressing the cytotoxicity of expanded CD8 cells. The molecular mechanism of suppression involves TGF-β because expression of a dominant-negative TGF-β receptor by tumor-specific CD8 cells renders them resistant to suppression and is associated with tumor rejection and unimpaired cytotoxicity.

Subfields: Conservation, History, Literature and Literary Theory

View Paper: https://www.semanticscholar.org/paper/29c0e621bfab4424b93ffb0181a07804fa3ece12

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. E. Batlle
  2. D. Pardoll
  3. M. Karin
  4. J. Massagué
  5. Wan-Wan Lin
  6. Charles G. Drake
  7. E. Jaffee
  8. E. Shevach

Citations in the corpus